Role of the IFNG +874T/A polymorphism in Chagas disease in a Colombian population

Infection, Genetics and Evolution

Volumn 10, Issue 5, 2010, Pages 682-685

  Torres, Orlando A ^a   Calzada, José E ^b   Beraún, Yasmina ^a   Morillo, Carlos A ^c   González, Antonio ^a   González, Clara I ^d   Martín, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b Instituto Conmemorativo Gorgas de Estudios de la Salud ICGES   (Panama)

^c FUNDACIÓN CARDIOVASCULAR DE COLOMBIA   (Colombia)

^d UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

Association study; Chagas disease; Genetics; IFN ; Single nucleotide polymorphism (SNP)

Indexed keywords

ADENINE; GAMMA INTERFERON; TYROSINE;

ADULT; ARTICLE; CARDIOMYOPATHY; CHAGAS DISEASE; COLOMBIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES ENDEMICITY; TRYPANOSOMA CRUZI;

ADULT; ANIMALS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; COLOMBIA; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERFERON-GAMMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRYPANOSOMA CRUZI;

TRYPANOSOMA CRUZI;

EID: 77953189157     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2010.03.009     Document Type: Article

References (32)

1. Calzada J.E., Beraun Y., Gonzalez C.I., Martin J. Transforming growth factor beta 1 (TGFbeta1) gene polymorphisms and Chagas disease susceptibility in Peruvian and Colombian patients. Cytokine 2009, 45:149-153.
2. Calzada J.E., Nieto A., Beraun Y., Martin J. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 2001, 58:154-158.
3. Cardillo F., Voltarelli J.C., Reed S.G., Silva J.S. Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect. Immun. 1996, 64:128-134.
4. Chong W.P., Ip W.K., Tso G.H., Ng M.W., Wong W.H., Law H.K., Yung R.W., Chow E.Y., Au K.L., Chan E.Y., Lim W., Peiris J.S., Lau Y.L. The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome. BMC Infect. Dis. 2006, 6:82.
5. D'Avila D.A., Guedes P.M., Castro A.M., Gontijo E.D., Chiari E., Galvao L.M. Immunological imbalance between IFN-gamma and IL-10 levels in the sera of patients with the cardiac form of Chagas disease. Mem. Inst. Oswaldo Cruz 2009, 104:100-105.
6. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol. Bioinform. Online 2005, 1:47-50.
7. Florez O., Zafra G., Morillo C., Martin J., Gonzalez C.I. Interleukin-1 gene cluster polymorphism in chagas disease in a Colombian case-control study. Hum. Immunol. 2006, 67:741-748.
8. Gomes J.A., Bahia-Oliveira L.M., Rocha M.O., Martins-Filho O.A., Gazzinelli G., Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect. Immun. 2003, 71:1185-1193.
9. Gutierrez R., Angulo V.M., Tarazona Z., Britto C., Fernandes O. Comparison of four serological tests for the diagnosis of Chagas disease in a Colombian endemic area. Parasitology 2004, 129:439-444.
10. Karplus T.M., Jeronimo S.M., Chang H., Helms B.K., Burns T.L., Murray J.C., Mitchell A.A., Pugh E.W., Braz R.F., Bezerra F.L., Wilson M.E. Association between the tumor necrosis factor locus and the clinical outcome of Leishmania chagasi infection. Infect. Immun. 2002, 70:6919-6925.
11. Kierszenbaum F. Chagas' disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 1999, 12:210-223.
12. Kumar S., Tarleton R.L. The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol. 1998, 20:207-216.
13. Lopez-Maderuelo D., Arnalich F., Serantes R., Gonzalez A., Codoceo R., Madero R., Vazquez J.J., Montiel C. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 2003, 167:970-975.
14. Martin D.L., Postan M., Lucas P., Gress R., Tarleton R.L. TGF-beta regulates pathology but not tissue CD8+ T cell dysfunction during experimental Trypanosoma cruzi infection. Eur. J. Immunol. 2007, 37:2764-2771.
15. Miller C.A., Martinat M.A., Hyman L.E. Assessment of aryl hydrocarbon receptor complex interactions using pBEVY plasmids: expressionvectors with bi-directional promoters for use in Saccharomyces cerevisiae. Nucleic Acids Res. 1998, 26:3577-3583.
16. Nieto A., Beraun Y., Collado M.D., Caballero A., Alonso A., Gonzalez A., Martin J. HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 2000, 55:195-198.
17. Pacheco A.G., Cardoso C.C., Moraes M.O. IFNG +874T/A, IL10-1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study. Hum. Genet. 2008, 123:477-484.
18. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect. Dis. 2001, 1:92-100.
19. Pravica V., Asderakis A., Perrey C., Hajeer A., Sinnott P.J., Hutchinson I.V. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur. J. Immunogenet. 1999, 26:1-3.
20. Pravica V., Perrey C., Stevens A., Lee J.H., Hutchinson I.V. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum. Immunol. 2000, 61:863-866.
21. Ramasawmy R., Cunha-Neto E., Fae K.C., Martello F.G., Muller N.G., Cavalcanti V.L., Ianni B., Mady C., Kalil J., Goldberg A.C. The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin. Infect. Dis. 2006, 43:305-311.
22. Ribeiro C.S., Visentainer J.E., Moliterno R.A. Association of cytokine genetic polymorphism with hepatitis B infection evolution in adult patients. Mem. Inst. Oswaldo Cruz 2007, 102:435-440.
23. Rocha M.O., Ribeiro A.L., Teixeira M.M. Clinical management of chronic Chagas cardiomyopathy. Front. Biosci. 2003, 8:e44-54.
24. Rodriguez-Perez J.M., Cruz-Robles D., Hernandez-Pacheco G., Perez-Hernandez N., Murguia L.E., Granados J., Reyes P.A., Vargas-Alarcon G. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol. Lett. 2005, 98:97-102.
25. Silva J.S., Morrissey P.J., Grabstein K.H., Mohler K.M., Anderson D., Reed S.G. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 1992, 175:169-174.
26. Silva J.S., Vespa G.N., Cardoso M.A., Aliberti J.C., Cunha F.Q. Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect. Immun. 1995, 63:4862-4867.
27. Torres O.A., Calzada J.E., Beraun Y., Morillo C.A., Gonzalez C.I., Gonzalez A., Martin J. Association of the macrophage migration inhibitory factor -173G/C polymorphism with Chagas disease. Hum. Immunol. 2009, 70:543-546.
28. Torrico F., Heremans H., Rivera M.T., Van Marck E., Billiau A., Carlier Y. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 1991, 146:3626-3632.
29. WHO, 1991. Control of Chagas disease. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 811, 1-95.
30. WHO, 2002a. Control of Chagas disease. World Health Organ Tech Rep Ser. 905, i-vi, 1-109, back cover.
31. WHO, 2002b. WHO expert committee on specifications for pharmaceutical preparations. World Health Organ Tech Rep Ser. 902, i-vii, 1-208.
32. Zafra G., Morillo C., Martin J., Gonzalez A., Gonzalez C.I. Polymorphism in the 3' UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes Infect. 2007, 9:1049-1052.